These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

352 related items for PubMed ID: 19808545

  • 1. Development of receptor for advanced glycation end products-directed imaging of atherosclerotic plaque in a murine model of spontaneous atherosclerosis.
    Tekabe Y, Li Q, Rosario R, Sedlar M, Majewski S, Hudson BI, Einstein AJ, Schmidt AM, Johnson LL.
    Circ Cardiovasc Imaging; 2008 Nov; 1(3):212-9. PubMed ID: 19808545
    [Abstract] [Full Text] [Related]

  • 2. [The Fc region of immunoglobulin suppresses atherosclerosis in apolipoprotein E knockout mice].
    Yuan ZY, Liu Y, Kishimoto C, Shioji K, Yokode M, Liu ZQ.
    Zhonghua Yi Xue Za Zhi; 2003 Mar 25; 83(6):489-93. PubMed ID: 12887764
    [Abstract] [Full Text] [Related]

  • 3. A novel monoclonal antibody for RAGE-directed imaging identifies accelerated atherosclerosis in diabetes.
    Tekabe Y, Luma J, Einstein AJ, Sedlar M, Li Q, Schmidt AM, Johnson LL.
    J Nucl Med; 2010 Jan 25; 51(1):92-7. PubMed ID: 20008983
    [Abstract] [Full Text] [Related]

  • 4. Prolonged high-fat feeding enhances aortic 18F-FDG and 99mTc-annexin A5 uptake in apolipoprotein E-deficient and wild-type C57BL/6J mice.
    Zhao Y, Kuge Y, Zhao S, Strauss HW, Blankenberg FG, Tamaki N.
    J Nucl Med; 2008 Oct 25; 49(10):1707-14. PubMed ID: 18794270
    [Abstract] [Full Text] [Related]

  • 5.
    Shan L.
    ; 2004 Oct 25. PubMed ID: 20734503
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Biodistribution properties of (111)indium-labeled C-functionalized trans-cyclohexyl diethylenetriaminepentaacetic acid humanized 3S193 diabody and F(ab')(2) constructs in a breast carcinoma xenograft model.
    Tahtis K, Lee FT, Smyth FE, Power BE, Renner C, Brechbiel MW, Old LJ, Hudson PJ, Scott AM.
    Clin Cancer Res; 2001 Apr 25; 7(4):1061-72. PubMed ID: 11309358
    [Abstract] [Full Text] [Related]

  • 15. Reduced in vivo aortic uptake of radiolabeled oxidation-specific antibodies reflects changes in plaque composition consistent with plaque stabilization.
    Torzewski M, Shaw PX, Han KR, Shortal B, Lackner KJ, Witztum JL, Palinski W, Tsimikas S.
    Arterioscler Thromb Vasc Biol; 2004 Dec 25; 24(12):2307-12. PubMed ID: 15528482
    [Abstract] [Full Text] [Related]

  • 16. Anti-heat shock protein 60 autoantibodies induce atherosclerosis in apolipoprotein E-deficient mice via endothelial damage.
    Foteinos G, Afzal AR, Mandal K, Jahangiri M, Xu Q.
    Circulation; 2005 Aug 23; 112(8):1206-13. PubMed ID: 16116071
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. A neutralizing antibody against receptor for advanced glycation end products (RAGE) reduces atherosclerosis in uremic mice.
    Bro S, Flyvbjerg A, Binder CJ, Bang CA, Denner L, Olgaard K, Nielsen LB.
    Atherosclerosis; 2008 Dec 23; 201(2):274-80. PubMed ID: 18371970
    [Abstract] [Full Text] [Related]

  • 19. Fractionated radioimmunotherapy of intraperitoneally growing ovarian cancer in nude mice with 211At-MX35 F(ab')2: therapeutic efficacy and myelotoxicity.
    Elgqvist J, Andersson H, Bäck T, Claesson I, Hultborn R, Jensen H, Lindegren S, Olsson M, Palm S, Warnhammar E, Jacobsson L.
    Nucl Med Biol; 2006 Nov 23; 33(8):1065-72. PubMed ID: 17127181
    [Abstract] [Full Text] [Related]

  • 20. Imaging atherosclerotic plaques by targeting Galectin-3 and activated macrophages using (89Zr)-DFO- Galectin3-F(ab')2 mAb.
    Varasteh Z, De Rose F, Mohanta S, Li Y, Zhang X, Miritsch B, Scafetta G, Yin C, Sager HB, Glasl S, Gorpas D, Habenicht AJR, Ntziachristos V, Weber WA, Bartolazzi A, Schwaiger M, D'Alessandria C.
    Theranostics; 2021 Nov 23; 11(4):1864-1876. PubMed ID: 33408786
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.